CYTOLOGICAL FINDINGS BEFORE AND AFTER PROBIOTICS (LACTOGYN)

Ž. Perišić ,
Ž. Perišić

OB/GYN Clinic ''Narodni front'', Medical faculty Belgrade , Belgrade , Serbia

D. Vukićević ,
D. Vukićević

Institute of Pathology, Medical faculty Pristina , Kosovska Mitrovica , Kosovo*

N. Perišić ,
N. Perišić

OB/GYN Clinic ''Narodni front'', Medical faculty Belgrade Serbia

S. Janković Ražnatović ,
S. Janković Ražnatović

OB/GYN Clinic ''Narodni front'', Medical faculty Belgrade , Belgrade , Serbia

L. Tasić ,
L. Tasić

OB/GYN Clinic ''Narodni front'', Medical faculty Belgrade , Belgrade , Serbia

Lj. Dimitrijević Lesendrić ,
Lj. Dimitrijević Lesendrić

OB/GYN Clinic ''Narodni front'', Medical faculty Belgrade , Belgrade , Serbia

M. Perišić ,
M. Perišić

Medical faculty Belgrade , Belgrade , Serbia

M. Perišić
M. Perišić

Medical faculty Belgrade , Belgrade , Serbia

Published: 01.01.2009.

Volume 37, Issue 1 (2009)

pp. 49-53;

https://doi.org/10.70949/pramed200901271P

Abstract

Probiotics help to provde optimum balance in the intestines probiotics species competitive blocks toxics substances and growth of unwanted species in their struggle for space and food. Lactogyn is the first oral probiotics wich protects vaginal flora. The most researced probiotic is the Lactobacillus rhamnosssus. The goal of this study is to exam influence of probiotics to cytological smear test including: reliability for easier detection of atypical cells; false positive and false negative test; faster cytodiagnostic; incidence of invasive diagnostic procedures and incidence of intraepithelial and invasive changes of the lower genital tract. This study involved two groups of patient: the first one included 50 patients who has been taken specific probiotic therapy after taking cytological cervical smear test. The second one included 50 patients who has taken specific probiotic therapy before taking cytological cervical smear test. In the second group we discovered: statistically lover number od invasive diagnostic and therapeutic methods and statistically higher number of patients without invasive methods. It was statistical higher incidence of cytological smears with inflammations and ASCUS (atypical squamous cells undetermined significance) in the second group of patients. Lactogyn treatment with other medicament therapy provides: faster and better cytological diagnostic, decreases the number of cytological tests and invasive diagnostics methods per women, decreases the number of false positive and false negative tests and the percent of unsatisfactory tests and borderline satisfactory tests

Keywords

References

1.
Spiegel CA. Bacterial vaginosis. Clin Microbiol Rev. 4(4):485–502.
2.
Myziuk L, Romanowski B, Johnson SC. BVBlue test for diagnosis of bacterial vaginosis. J Clin Microbiol. 41:1925–8.
3.
Klebanoff MA, Schwebke Z, J N, TR Y, KF A, W.W. Vulvovaginal symptoms in women with bacterial vaginosis. Obstet Gynecol. 104(2):267–72.
4.
Morelli L, Zonenenschain D, Del Piano M, Cognein P. Utilization of the intestinal tract as a delivery system for urogenital probiotics. Clin Gastroenterol. 38(6 Suppl).
5.
6.
Reid G, Beuerman D, Heinemann C, Bruce AW. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol. 32(1):37–41.
7.
Ness RB, Hillier S, Richter HE, Soper DE, Stamm C, Bass DC, et al. Can known risk factors explain racial differences in the occurrence of bacterial vaginosis? J Natl Med Assoc. 95(3):201–12.
8.
Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol. 35(2):131–4.
9.
Burton JP, Cadieux PA, Reid G. Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl Environ Microbiol. 69(1):97–101.
10.
Reid G. The extraintestinal effects of probiotics.
11.
Andreeva PM, Omar HA. Effectiveness of current therapy of bacterial vaginosis. Int J Adolesc Med Health. 14(2):145–8.
12.
Huang M, Wang JH. Gram stain as a relapse predictor of bacterial vaginosis after metronidazole treatment. J Microbiol Immunol Infect. 38(2):137–40.
13.
Paavonen J, Mangioni C, Martin MA, Wajszczuk CP. Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial. Obstet Gynecol. 96(2):256–60.
14.
Beigi RH, Austin MN, Meyn LA, Krohn MA, Hillier SL. Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol. 191(4):1124–9.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by